Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...
Next year is going to be a big one for Formula 1. For the first time in quite a while there will be 11 teams on the grid, including new comers Audi and Cadillac. Ford and Honda are also returning as ...
Formula 1 teams are understood to be asked that, if they have not revealed their F1 2026 liveries by the time the first behind-closed-doors test takes place in Barcelona in January, a request has come ...
Alkhatib, a Gazan native and anti-Hamas activist who resides in the US, shared video footage of the "literal tons of infant formula and nutritional shakes," which he says were hidden "during the worst ...
F1 is getting a makeover at more than 200 miles per hour, with next season set to feature new teams, a new race and entirely new cars. The 2025 Formula 1 season is in the books, but F1 cars will be ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...
Thalapathy Vijay's son, Jason Sanjay, is set to make his directorial debut with the Tamil film 'Sigma', starring Sundeep Kishan. A dance number featuring Catherine Tresa is creating buzz and is ...
Getting your Trinity Audio player ready... The University of Colorado Boulder suspended the Phi Kappa Sigma fraternity after “credible reports of hazing” regarding the group. The university announced ...
Two Sigma Investments launched a hedge fund that jumps on one of the hottest trends in wealth management: minimizing taxes. The quantitative firm debuted Two Sigma Beacon Fund this year, a so-called ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback